Teva shares slide on generic Copaxone fears

April 19, 2015 1:16 PM

53 0

Teva shares slide on generic Copaxone fears

TEL AVIV (Reuters) - Teva Pharmaceutical Industries shares slid five percent on Sunday after U.S. regulators approved a generic version of its top-selling multiple sclerosis drug and amid reports it was mulling a bid for rival Mylan.

Teva's Tel Aviv shares fell to 249.80 shekels ($64) late on Sunday, the first day of trading since both news hit the market on Thursday after Israel's market closed for the weekend. Teva's New York-listed shares fell 3.8 percent on Thursday but gained 2.2 percent on Friday, ending the week at $64.91...

Also read: Coke profit falls 28 percent, but beats expectations

Read more

To category page